tiprankstipranks
Belite Bio price target raised to $100 from $60 at H.C. Wainwright
PremiumThe FlyBelite Bio price target raised to $100 from $60 at H.C. Wainwright
3M ago
Belite Bio Advances in Retinal Disease Trials
Premium
Company Announcements
Belite Bio Advances in Retinal Disease Trials
3M ago
Belite Bio Advances in Tinlarebant Trials, Appoints New CMO
Premium
Company Announcements
Belite Bio Advances in Tinlarebant Trials, Appoints New CMO
3M ago
Belite Bio Welcomes New Chief Medical Officer
PremiumCompany AnnouncementsBelite Bio Welcomes New Chief Medical Officer
5M ago
Belite Bio announces appointment of Hendrik Scholl as Chief Medical Officer
Premium
The Fly
Belite Bio announces appointment of Hendrik Scholl as Chief Medical Officer
5M ago
Belite Bio price target raised to $60 from $59 at H.C. Wainwright
Premium
The Fly
Belite Bio price target raised to $60 from $59 at H.C. Wainwright
6M ago
Belite Bio Advances Retinal Disease Treatment
PremiumCompany AnnouncementsBelite Bio Advances Retinal Disease Treatment
9M ago
Belite Bio reports Q1 EPS (33c), consensus (28c)
Premium
The Fly
Belite Bio reports Q1 EPS (33c), consensus (28c)
9M ago
Belite Bio participates in a webinar with Cantor Fitzgerald
Premium
The Fly
Belite Bio participates in a webinar with Cantor Fitzgerald
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100